ASLAN Pharmaceuticals (ASLAN Pharmaceuticals) Price-to-Tangible-Book : (As of Jun. 06, 2024)

View and export this data going back to 2018. Start your Free Trial

What is ASLAN Pharmaceuticals Price-to-Tangible-Book?

As of today (2024-06-06), ASLAN Pharmaceuticals's share price is $0.48. ASLAN Pharmaceuticals's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was $-0.79. Hence, ASLAN Pharmaceuticals's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for ASLAN Pharmaceuticals's Price-to-Tangible-Book or its related term are showing as below:

During the past 10 years, ASLAN Pharmaceuticals's highest Price to Tangible Book Ratio was 15.31. The lowest was 1.06. And the median was 3.01.

ASLN's Price-to-Tangible-Book is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.825
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, ASLAN Pharmaceuticals's share price is $0.48. ASLAN Pharmaceuticals's Book Value per Sharefor the quarter that ended in Mar. 2024 was $-0.79. Hence, ASLAN Pharmaceuticals's P/B Ratio of today is .

ASLAN Pharmaceuticals Price-to-Tangible-Book Historical Data

The historical data trend for ASLAN Pharmaceuticals's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ASLAN Pharmaceuticals Price-to-Tangible-Book Chart

ASLAN Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

1.36

3.01

ASLAN Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Tangible-Book	Get a 7-Day Free Trial															4.76	9.55	-	-	-

Competitive Comparison of ASLAN Pharmaceuticals's Price-to-Tangible-Book

For the Biotechnology subindustry, ASLAN Pharmaceuticals's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ASLAN Pharmaceuticals's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ASLAN Pharmaceuticals's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where ASLAN Pharmaceuticals's Price-to-Tangible-Book falls into.

ASLAN Pharmaceuticals Price-to-Tangible-Book Calculation

ASLAN Pharmaceuticals's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Mar. 2024 )
	=	0.48	/	-0.794
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

ASLAN Pharmaceuticals Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of ASLAN Pharmaceuticals's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

ASLAN Pharmaceuticals (ASLAN Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ASLAN Pharmaceuticals Ltd (NAS:ASLN) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

3 Temasek Avenue, Level 18, Centennial Tower, Singapore, SGP, 039190

Website

https://www.aslanpharma.com

ASLAN Pharmaceuticals Ltd is a clinical-stage immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients. The company is evaluating ASLAN004, a potential first-in-class antibody targeting the IL-13 receptor, in atopic dermatitis, and ASLAN003, a potent oral inhibitor of DHODH, which is being developed for autoimmune disease.